Late Breaking Abstract - Anaplastic Lymphoma Kinase inhibition as an effective treatment strategy against the enhanced lung carcinogenesis and cancer angiogenesis related to decreased PTPRZ1 expression

D. Ntenekou (Patras, Greece), P. Kastana (Patras, Greece), M. Hatziapostolou (Nottingham, United Kingdom), C. Polytarchou (Nottingham, United Kingdom), A. Marazioti (Patras, Greece), S. Nikou (Patras, Greece), G. Herradon (Madrid, Spain), E. Papadaki (Patras, Greece), G. Stathopoulos (Patras, Greece), C. Mikelis (Amarillo, TX, United States of America), E. Papadimitriou (Patras, Greece)

Source: Virtual Congress 2020 – Biological aspects of lung cancer
Session: Biological aspects of lung cancer
Session type: Oral Presentation
Number: 3939
Disease area: Thoracic oncology

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Ntenekou (Patras, Greece), P. Kastana (Patras, Greece), M. Hatziapostolou (Nottingham, United Kingdom), C. Polytarchou (Nottingham, United Kingdom), A. Marazioti (Patras, Greece), S. Nikou (Patras, Greece), G. Herradon (Madrid, Spain), E. Papadaki (Patras, Greece), G. Stathopoulos (Patras, Greece), C. Mikelis (Amarillo, TX, United States of America), E. Papadimitriou (Patras, Greece). Late Breaking Abstract - Anaplastic Lymphoma Kinase inhibition as an effective treatment strategy against the enhanced lung carcinogenesis and cancer angiogenesis related to decreased PTPRZ1 expression. 3939

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: